Lumbar Joint Injections: Why “Where You Inject” Changes the Meaning — Intra-articular, Peri-articular, Perineural, and How They Differ from Nerve Blocks2026.07.12

“I want an injection for my back pain” is a request we hear every day. But even within “lumbar joint injection,” the target effect and the expected duration change completely depending on where and what is injected. Injections directly into the joint, approaches to surrounding tendons and fascia, and nerve blocks along the course of the nerves — all fall under the umbrella of “lumbar injection,” yet their aims and indications are entirely different. In this article, Dr. Moriwaki explains the way to think about “where to inject” before considering a lumbar joint injection using stem cell conditioned media.

Key Points of This Article

– A lumbar joint injection can be intra-articular, peri-articular, or perineural, and the purpose differs significantly depending on the layer.

– Stem cell conditioned media may be considered for joint-origin inflammation in the facet or sacroiliac joints.

– Radicular symptoms from nerve root compression or spinal stenosis are not a direct target of injections aimed at the joint itself.

– Deciding “where to inject” on the basis of a clear diagnosis is the single most important step in avoiding unnecessary injections.

– Individual variation exists, and combining injection with rehabilitation and exercise therapy strongly influences the outcome.

“Lumbar Injection” Is Not a Single Thing

Injection therapy for low back pain has historically included many techniques, and their purposes and target sites differ. Intra-articular injection places medication into the joint itself; peri-articular injection targets the ligaments, fascia, and tendon attachments around the joint; nerve block injection delivers a local anesthetic along the course of a nerve. Even when someone says “an injection into the back,” the actual practice is highly varied. If a patient asks for a “lumbar joint injection” without this distinction in mind, the intended effect and the actual effect can end up misaligned.

The Three-Layer Roles: Intra-articular, Peri-articular, and Perineural

When the joint itself is the source of pain — such as the facet joints of the lumbar spine or the sacroiliac joint at the back of the pelvis — direct delivery into the joint is a rational choice. If the pain comes from stiffened tendon attachments or fascial insertions, a peri-articular approach that targets the surrounding tissues is more appropriate. When inflammation or entrapment of a nerve root causes radiating pain or numbness in the leg, a nerve block with local anesthetic and steroid has traditionally been performed. Even with the same “low back pain,” if the source layer differs, both the target site and the medication must change.

How the Purpose Differs from a Nerve Block

A nerve block is, in principle, aimed at “temporarily interrupting the transmission of pain.” It targets relief that lasts from the hours of local anesthetic action to, when combined with steroid, a few weeks. In contrast, a lumbar joint injection using stem cell conditioned media does not aim to block pain but to act on the inflammatory environment inside the joint and prepare a foundation for tissue repair. Because purpose and evaluation axis differ, the choice should not be “which is superior” but “which is appropriate for the current source of pain.”

Layers Where Stem Cell Conditioned Media Can Aim

Stem cell conditioned media contains multiple growth factors and anti-inflammatory cytokines at the basic-research level, and intra-articular delivery is expected to intervene in the intra-articular inflammatory cycle. However, there is a distance between the expected mechanism of action and actual clinical effect, and indication and limitation need to be considered separately.

Facet and Sacroiliac Inflammation as “Joint-Origin” Pain

When a diagnosis of facet joint syndrome or sacroiliac joint dysfunction is established, delivery of stem cell conditioned media may be considered with the aim of calming intra-articular synovitis and preparing an environment for tissue repair. This is a relatively rational area for joint-origin pain. However, in end-stage cases with severe joint destruction, or when spinal instability is the main driver, improvement is unlikely to be achieved by injection alone. Determining whether the diagnosis is at “a stage the injection can target” — through imaging and physical examination — is the prerequisite.

Peri-articular and Tendon Attachment Approaches

For lumbar tendon insertion inflammation or myofascial pain in the gluteal muscles, a peri-articular approach that delivers stem cell conditioned media to the surrounding tissues rather than the joint itself becomes an option. The aim is to prepare a repair environment at tendon attachments that have limited blood flow, but tendon tissue heals slowly, and effect judgment requires a timeframe of several weeks to several months. This is not a treatment to expect immediate results from; it is a treatment where sharing the premise of “judging while following the course” is essential.

Diagnostic Steps for Deciding “Where to Inject”

Order: History, Physical Findings, Imaging

When considering a lumbar joint injection, it is not appropriate to jump straight to “let’s treat it with an injection.” First, history-taking clarifies onset, aggravating movements, and the presence or absence of leg symptoms. Physical findings help estimate whether the origin is facet, sacroiliac, or nerve root. Then X-ray and MRI confirm the presence or absence of facet arthrosis, disc herniation, or spinal stenosis, and the injection site is decided. Only when diagnosis comes first does conditioned media delivery become a meaningful choice.

Not Confusing Nerve-Origin Pain with Joint-Origin Pain

When radiating pain and numbness in the leg are strong, the main driver of pain is often nerve compression or inflammation, and injection into the joint itself is not necessarily the first choice. In particular, when neurogenic claudication from spinal stenosis or sciatica from disc herniation is suspected, injection into the joint offers no guarantee of relief for leg symptoms, and it is necessary to honestly draw the line between what can and cannot be targeted. General information on joint disease can also be referenced from the Japanese Orthopaedic Association.

Honestly Communicating the Indications and Limits of Lumbar Joint Injection

A lumbar joint injection using stem cell conditioned media is a worth-considering option for “joint-origin inflammation and pain” in the facet and sacroiliac joints, but it is not a cure-all. Individual variation exists, and rather than standing alone, combination with exercise therapy — posture review, core strengthening, adjustment of daily movements — strongly influences the outcome. It is not a treatment that guarantees dramatic improvement in a single session; the important attitude is to judge additional delivery and revision of the treatment plan while following the course. Please also refer to the details of stem cell conditioned media joint injections.

Frequently Asked Questions

Q. How often should a lumbar joint injection be received?

The design changes depending on symptoms and imaging findings, but after the first dose, we observe the course for several weeks to several months, evaluate changes in pain, range of motion, and daily activities, and then judge the need for additional delivery. The basic principle is to build the plan by course, not by number of sessions.

Q. Can a nerve block and stem cell conditioned media be received at the same time?

Because the two have different purposes, combined use may be considered depending on symptoms. However, timing and site design should be decided in consultation with the physician in charge; stacking multiple injections by self-judgment is not recommended.

Q. Does injection into the joint help symptoms of spinal stenosis?

Leg numbness and intermittent claudication from spinal stenosis are mainly driven by nerve compression, so injection into the joint itself does not guarantee improvement. Based on neurological evaluation, other treatment options should be considered when appropriate.

Q. How long does it take to feel the effect?

Because the treatment acts on the intra-articular inflammatory environment, it differs from the immediate effect of local anesthesia. It is common to evaluate the course over several weeks to several months, and the plan is reviewed if change is limited.

Q. What side effects can occur?

Temporary swelling, bruising, and pain at the injection site have been reported. Rarely there are risks of infection or nerve injury, so a comprehensive judgment covering facility choice, technique, and post-procedure management is important.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member of the Japan Society of Aesthetic Surgery (JSAS)

Member of the American Academy of Aesthetic Medicine

U.S. Medical License (ECFMG certificate)

──────────────

📍AVAN TOKYO 銀座 再生医療

AVAN TOKYO Ginza Regenerative Medicine

English / 中文 / Tiếng Việt available.

For consultation, please contact us via DM / LINE / Website / Phone.